COFCO Biotech: citric acid sales declines in 2023

COFCO Biotechnology Co., Ltd. (COFCO Biotech)'s citric acids and the derivatives business was on a downswing in 2023:Revenue: USD135.04 million (RMB959.97 million), down 41.31% YoYOperating cost: USD11.93 million (RMB80.99 million), down 10.03% YoY C...

Acidity Regulator Quarterly China Report Q2 2024

www.cnchemicals.com